Overview VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome. Status: Recruiting Trial end date: 2021-12-01 Target enrollment: Participant gender: Summary A Study of Vurolenatide in Adult Patients with Short Bowel Syndrome. Phase: Phase 2 Details Lead Sponsor: 9 Meters Biopharma, Inc.